Evidence map›Paper›PMID 36593836›Full record

ArticleHeliyon2022

Severe hypertrophic cardiomyopathy in a patient with a homozygous MYH7 gene variant.

Walter Serra, Giulia Vitetta, Vera Uliana, Federico Barocelli, Valeria Barili, Isabella Allegri, Diego Ardissino, Francesca Gualandi, Antonio Percesepe

Open access · goldAbstract readCase Reports
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Walter SerraCardiology Division, University Hospital of Parma, Italy.
Giulia VitettaMedical Genetics Unit, University Hospital of Parma, Italy.
Vera UlianaMedical Genetics Unit, University Hospital of Parma, Italy.
Federico BarocelliCardiology Division, University Hospital of Parma, Italy.
Valeria BariliMedical Genetics, Department of Medicine and Surgery, University of Parma, Italy.
Isabella AllegriNeurology Unit, University Hospital of Parma, Italy.
Diego ArdissinoCardiology Division, University Hospital of Parma, Italy.
Francesca GualandiMedical Genetics Service, Department of Mother and Child, University Hospital S. Anna, Ferrara, Italy.
Antonio PercesepeMedical Genetics, Department of Medicine and Surgery, University of Parma, Italy.
University of Parma · ITArcispedale Sant'Anna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hypertrophic cardiomyopathy is an autosomal dominant disease. The main feature of this disorder is its occurrence in patients who present a left ventricular hypertrophy, unexplained by the loading conditions, usually asymmetric with greatest involvement most commonly of the interventricular septum.Case presentation During a sports medicine control, a ultrasound scan in a 17 years old patient has shown a concentric left ventricular parietal hypertrophy associated with a 23 mm mid- basal interventricular septum thickness. After genetic counselling, a positive family history for hypertrophic cardiac disease and parents' consanguineity was found. The genetic basis of the hypertrophic cardiomyopathy was investigated through a dedicated gene panel. The genetic test has revealed the presence of the variant c.3424G>A (p.Glu1142Lys) in the MYH7 gene in a homozygous state. Genotyping of the parents and of the two brothers revealed the presence of the MYH7 variant in heterozygosity in both parents and in the younger brother. In all of them, variable signs of hypertrophic cardiomyopathy were found. Conclusions: Our findings report the presence of a homozygous variant in a sarcomeric gene (MYH7) which gave rise to early HCM, whereas the variant in a heterozygous state was associated to much milder cardiac phenotypes in the affected relatives. The onset and the progression of the hypertrophic cardiomyopathy in the reported family is to be referred to the presence of the variant in hetero- or homo-zygosity in a gene dosage manner.

Indexed as

Genetic analysisHypertrophic cardiomyopathyImaging

Identifiers

PMID36593836
PMCPMC9803765
OpenAlexW4311755253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.